Juvenile parkinsonism, hypogonadism and Leigh-like MRI changes in a patient with m.4296G>A mutation in mitochondrial DNA
Highlights
► Leigh syndrome is a mitochondrial disease with large clinical and genetic variation. ► A 16-year-old boy presented with Leigh-like syndrome, parkinsonism and hypogonadism. ► Sequencing of the entire mtDNA revealed the m.4296G>A mutation in the MT-TI gene. ► We suggest that the m.4296G>A mutation is pathogenic and causes Leigh-like syndrome.
Introduction
Mitochondria are essential intracellular organelles that undertake many vital metabolic functions. The primary function of mitochondria is the production of ATP from ADP by the process of oxidative phosphorylation (OXPHOS). This process is dependent upon five multisubunit enzyme complexes that are under dual genetic control. Mitochondrial DNA (mtDNA) encodes 13 of the more than 80 subunits in these respiratory chain (RC) complexes and, in addition, the two rRNAs, and 22 tRNAs required in mitochondrial protein synthesis.
Mitochondrial disease refers primarily to pathological conditions that result from abnormal function of RC resulting in defective OXPHOS. Leigh syndrome (LS) is an extremely variable and multi-etiological entity in mitochondrial disease (Finsterer, 2008). Typically, LS is a devastating encephalopathy of infants and children, and results from a severe OXPHOS defect. Characteristic clinical features of LS include progressive psychomotor regression, hypotonia, ataxia, seizures, respiratory difficulties, dystonia, and problems with swallowing (Dahl, 1998). Brain imaging shows bilateral necrotizing lesions within the basal ganglia, thalami and in the brainstem (Lee et al., 2009). Lactate concentration is commonly elevated in blood and CSF. Genetic etiology of LS is highly variable. These include mtDNA deletions as well as mtDNA point mutations; the most common of these being m.8993T>G and m.8993T>C in the MTATP6 gene encoding the FO subunit 6 of complex V (Makino et al., 2000, Uziel et al., 2011) in the mitochondrial RC. Mutations in several autosomal genes also result in LS, such as mutations in SURF1, encoding an assembly factor of RC complex IV (cytochrome c oxidase), and mutations in several complex I subunit-encoding genes (Lee et al., 2012, Uziel et al., 2011).
‘Leigh-like’ syndrome refers to cases that are clinically or neuroradiologically suggestive of LS but do not fulfill the stringent criteria (Rahman et al., 1996). These patients may present with milder phenotypes of mitochondrial disease that resemble LS, sometimes with onset of symptoms in adolescence or adulthood. Here we present a case of a Leigh-like syndrome in an adolescent boy with the clinical features of parkinsonism, cognitive decline and hypogonadism. Sequencing of the entire mtDNA revealed heteroplasmic m.4296G>A mutation in the MT-TI gene encoding mitochondrial tRNAIle.
Section snippets
Case report
The patient is a boy, whose prenatal and early development had been unremarkable, though obstipation was noted already in the first year of life, and he had gained weight slowly. He learned to walk at age 13 months. He first presented to a pediatrician at age 9 years, because of overweight, excessive sweating, and suspected hypogonadism. At that time, he was 135.7 cm and 42.1 kg; (BMI 31.0), but otherwise clinical examination was unremarkable. No further investigations were performed. The boy's
Clinical investigations
At age 16 years, the patient was investigated thoroughly by a child neurologist. The work-up included brain magnetic resonance (MR) imaging, heart ultrasound, electrocardiography (ECG), electroencephalography (EEG), cerebrospinal fluid (CSF) examination, electrophysiological and histopathological examination of the skeletal muscle, nerve conduction velocities, comprehensive laboratory examinations of blood and urine, and genetic investigations on DNA extracted from blood.
Molecular methods
DNA purification from
The index patient
Brain MR imaging at age 16 years revealed subacute, bilateral abnormalities in the putamina and the caudate nuclei were oedemic (Fig. 1A). Thirteen months later, chronic, necrotic changes were seen in the same brain regions (Fig. 1B). The imaging findings suggested a Leigh-like mitochondrial disorder. Heart ultrasound and ECG were normal. EEG revealed slight general disturbance but no epileptiform abnormalities. CSF was normal including lactate (2.4 mmol/l; laboratory reference, 0.6–2.7 mmol/l).
Discussion
We found an adolescent boy with Leigh-like syndrome and clinical features of parkinsonism, cognitive decline and hypogonadism, who harbored the heteroplasmic m.4296G>A mutation in mtDNA. This mutation has previously been reported in oncocytic pituitary adenoma cells (Porcelli et al., 2010) and in a patient with infantile LS (Cox et al., 2012). The brain MRI findings of our patient were considered compatible with LS, but otherwise the phenotype was clearly different from that reported recently
References (41)
- et al.
Sporadic mitochondrial myopathy due to a new mutation in the mitochondrial tRNASer(UCN) gene
Neuromuscul. Disord.
(2004) - et al.
Leigh syndrome caused by a novel m.4296G>A mutation in mitochondrial tRNA isoleucine
Mitochondrion
(2012) Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome
Am. J. Hum. Genet.
(1998)- et al.
Phylogenetic network for European mtDNA
Am. J. Hum. Genet.
(2001) Leigh and Leigh-like syndrome in children and adults
Pediatr. Neurol.
(2008)- et al.
Atypical presentations of Leigh syndrome: a case series and review
Pediatr. Neurol.
(2005) - et al.
Leigh syndrome: clinical and neuroimaging follow-up
Pediatr. Neurol.
(2009) - et al.
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study
Lancet
(2004) - et al.
Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene
Parkinsonism Relat. Disord.
(2008) - et al.
Neuroimaging of mitochondrial disease
Mitochondrion
(2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Lancet Neurol.
Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene
Biochem. Biophys. Res. Commun.
Infantile mitochondrial encephalopathy
Semin. Fetal Neonatal. Med.
Mitochondrial tRNA(Thr) mutations and lethal infantile mitochondrial myopathy
Am. J. Hum. Genet.
Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as an extrapyramidal syndrome
J. Child Neurol.
Parkinson's syndrome and Parkinson's disease in mitochondrial disorders
Mov. Disord.
Human mitochondrial database
Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys
Neurology
Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA
Brain
Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing
Proc. Natl. Acad. Sci. U. S. A.
Cited by (18)
Complex neurological and multisystem presentations in mitochondrial disease
2023, Handbook of Clinical NeurologyParkinsonism and ataxia
2022, Journal of the Neurological SciencesCitation Excerpt :Cerebellar ataxia is a common feature of the highly pleiotropic clinical picture of mitochondrial disorders. In contrast, only a few mtDNA mutations have been reported in association with parkinsonism in families of patients suffering from Myoclonus epilepsy, ataxia, and myopathy with ragged red fibers (MERRF) [89], with Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) [90], Leber's optic neuropathy (LHON) [91] and Leigh-like syndrome [92]. Mutations in the nuclear gene of mitochondrial DNA polymerase gamma (POLG) are a cause of mtDNA depletion and can induce various possible pathological phenotypes, with onset from infancy to late adulthood [93].
Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments
2019, MitochondrionCitation Excerpt :LS (also known as subacute necrotizing encephalomyelopathy) is a progressive neurodegenerative disorder of the central nervous system that primarily affects the spinal cord, basal ganglia, pons, cerebellum and thalamus, as well as causes demyelination of optic nerves (Westarp et al., 1992; Duff et al., 2015; Gerards et al., 2016). Other mtDNA mutations, such as m.4296G>A (tRNAIle) (Martikainen et al., 2013), m.5523T>G and m.5559A>G (tRNATrp) (Mkaouar-Rebai et al., 2009), m.13513G>A (ND5) (Shanske et al., 2008), m.13514A>G (ND5) (Bannwarth et al., 2013), m.9191T>C (ATP6) (Moslemi et al., 2005) and m.9478T>C (COIII) (Mkaouar-Rebai et al., 2011), are also reportedly associated with LS (Fig. 1). The ailment has an incidence rate of one in 40,000 live births (Lake et al., 2015).
Movement Disorders Associated with Hypogonadism
2021, Movement Disorders Clinical Practice